Renaissance Technologies’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$581K Sell
49,900
-55,985
-53% -$652K ﹤0.01% 2760
2025
Q1
$787K Sell
105,885
-123,900
-54% -$921K ﹤0.01% 2547
2024
Q4
$1.38M Buy
229,785
+60,385
+36% +$362K ﹤0.01% 2301
2024
Q3
$867K Buy
169,400
+17,600
+12% +$90.1K ﹤0.01% 2533
2024
Q2
$550K Buy
151,800
+99,217
+189% +$359K ﹤0.01% 2656
2024
Q1
$169K Buy
+52,583
New +$169K ﹤0.01% 3268
2023
Q4
Sell
-51,200
Closed -$279K 3694
2023
Q3
$279K Sell
51,200
-287,300
-85% -$1.57M ﹤0.01% 2960
2023
Q2
$2.27M Sell
338,500
-55,500
-14% -$372K ﹤0.01% 1919
2023
Q1
$3.48M Sell
394,000
-21,800
-5% -$192K ﹤0.01% 1691
2022
Q4
$3.18M Sell
415,800
-42,000
-9% -$321K ﹤0.01% 1779
2022
Q3
$3.26M Sell
457,800
-28,700
-6% -$204K ﹤0.01% 1709
2022
Q2
$3.94M Buy
486,500
+30,900
+7% +$250K ﹤0.01% 1733
2022
Q1
$6.32M Buy
+455,600
New +$6.32M 0.01% 1423
2021
Q2
Sell
-160,200
Closed -$6.45M 3417
2021
Q1
$6.45M Buy
+160,200
New +$6.45M 0.01% 1495